HN1999000097A - Terapia de combinacion para la fragilidad muscoloesqueletica - Google Patents

Terapia de combinacion para la fragilidad muscoloesqueletica

Info

Publication number: HN1999000097A
Authority: HN; Honduras
Prior art keywords: muscoloskeletal; fragility; combination therapy; ghs; serm
Prior art date: 1998-06-16

Application number

HN1999000097A

Other languages

English (en)

Spanish (es)

Inventor

Pfizer Products Inc

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-16

Filing date

1999-06-15

Publication date

1999-11-03

1999-06-15 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

1999-11-03 Publication of HN1999000097A publication Critical patent/HN1999000097A/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Physical Education & Sports Medicine (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

HN1999000097A 1998-06-16 1999-06-15 Terapia de combinacion para la fragilidad muscoloesqueletica HN1999000097A (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US8946998P	1998-06-16	1998-06-16

Publications (1)

Publication Number	Publication Date
HN1999000097A true HN1999000097A (es)	1999-11-03

Family

ID=22217825

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HN1999000097A HN1999000097A (es)	1998-06-16	1999-06-15	Terapia de combinacion para la fragilidad muscoloesqueletica

Country Status (30)

Country	Link
EP (1)	EP1087764A1 (no)
JP (1)	JP2002518326A (no)
KR (1)	KR20010052852A (no)
CN (1)	CN1301160A (no)
AP (1)	AP9901582A0 (no)
AR (1)	AR018869A1 (no)
AU (1)	AU4054799A (no)
BG (1)	BG105041A (no)
BR (1)	BR9911324A (no)
CA (1)	CA2335134A1 (no)
CO (1)	CO5070587A1 (no)
EA (1)	EA200001186A1 (no)
GT (1)	GT199900087A (no)
HN (1)	HN1999000097A (no)
HR (1)	HRP20000859A2 (no)
HU (1)	HUP0102505A3 (no)
ID (1)	ID27599A (no)
IL (1)	IL138630A0 (no)
IS (1)	IS5691A (no)
MA (1)	MA26652A1 (no)
NO (1)	NO20006312D0 (no)
OA (1)	OA11505A (no)
PA (1)	PA8475901A1 (no)
PE (1)	PE20000646A1 (no)
PL (1)	PL344981A1 (no)
SK (1)	SK18912000A3 (no)
TN (1)	TNSN99124A1 (no)
TR (1)	TR200003544T2 (no)
WO (1)	WO1999065486A1 (no)
ZA (1)	ZA993975B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2360103A1 (en) *	1999-02-08	2000-08-17	Robert Sladek	Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding orphan nuclear receptor erralpha
DE60124616T2 (de)	2000-05-08	2007-09-13	Pfizer Products Inc., Groton	Enzymatische Spaltung von selektiven Modulatoren des Östrogenrezeptors
CA2420535A1 (en) *	2000-08-30	2002-03-07	Mary Tanya Am Ende	Sustained release formulations for growth hormone secretagogues
IL145106A0 (en) *	2000-08-30	2002-06-30	Pfizer Prod Inc	Intermittent administration of a geowth hormone secretagogue
US7476653B2 (en) *	2003-06-18	2009-01-13	Tranzyme Pharma, Inc.	Macrocyclic modulators of the ghrelin receptor
WO2006024931A2 (en) *	2004-08-31	2006-03-09	Pfizer Products Inc.	Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
CU23558A1 (es)	2006-02-28	2010-07-20	Ct Ingenieria Genetica Biotech	Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
ES2602789T3 (es)	2007-02-09	2017-02-22	Ocera Therapeutics, Inc.	Productos intermedios conectores para la síntesis de moduladores macrocíclicos del receptor de la grelina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA51676C2 (uk) *	1995-11-02	2002-12-16	Пфайзер Інк.	(-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) *	1995-12-28	2001-05-01	Pfizer	Pyrazolopyridine compounds
HN1996000101A (es) *	1996-02-28	1997-06-26	Inc Pfizer	Terapia combinada para la osteoporosis

1999
- 1999-06-15 PE PE1999000528A patent/PE20000646A1/es not_active Application Discontinuation
- 1999-06-15 AP APAP/P/1999/001582A patent/AP9901582A0/en unknown
- 1999-06-15 HN HN1999000097A patent/HN1999000097A/es unknown
- 1999-06-15 PA PA19998475901A patent/PA8475901A1/es unknown
- 1999-06-15 AR ARP990102848A patent/AR018869A1/es not_active Application Discontinuation
- 1999-06-15 ZA ZA9903975A patent/ZA993975B/xx unknown
- 1999-06-16 TN TNTNSN99124A patent/TNSN99124A1/fr unknown
- 1999-06-16 EA EA200001186A patent/EA200001186A1/ru unknown
- 1999-06-16 CA CA002335134A patent/CA2335134A1/en not_active Abandoned
- 1999-06-16 BR BR9911324-4A patent/BR9911324A/pt not_active Application Discontinuation
- 1999-06-16 CO CO99037622A patent/CO5070587A1/es unknown
- 1999-06-16 MA MA25628A patent/MA26652A1/fr unknown
- 1999-06-16 KR KR1020007014186A patent/KR20010052852A/ko not_active Application Discontinuation
- 1999-06-16 IL IL13863099A patent/IL138630A0/xx unknown
- 1999-06-16 TR TR2000/03544T patent/TR200003544T2/xx unknown
- 1999-06-16 JP JP2000554366A patent/JP2002518326A/ja active Pending
- 1999-06-16 EP EP99923802A patent/EP1087764A1/en not_active Withdrawn
- 1999-06-16 ID IDW20002627A patent/ID27599A/id unknown
- 1999-06-16 SK SK1891-2000A patent/SK18912000A3/sk unknown
- 1999-06-16 GT GT199900087A patent/GT199900087A/es unknown
- 1999-06-16 AU AU40547/99A patent/AU4054799A/en not_active Abandoned
- 1999-06-16 WO PCT/IB1999/001117 patent/WO1999065486A1/en not_active Application Discontinuation
- 1999-06-16 CN CN99806237A patent/CN1301160A/zh active Pending
- 1999-06-16 HU HU0102505A patent/HUP0102505A3/hu unknown
- 1999-06-16 PL PL99344981A patent/PL344981A1/xx not_active Application Discontinuation
2000
- 2000-10-20 OA OA1200000290A patent/OA11505A/en unknown
- 2000-10-27 IS IS5691A patent/IS5691A/is unknown
- 2000-12-11 BG BG105041A patent/BG105041A/xx unknown
- 2000-12-12 NO NO20006312A patent/NO20006312D0/no not_active Application Discontinuation
- 2000-12-14 HR HR20000859A patent/HRP20000859A2/hr not_active Application Discontinuation

Also Published As

Publication number	Publication date
ID27599A (id)	2001-04-12
CN1301160A (zh)	2001-06-27
EP1087764A1 (en)	2001-04-04
PE20000646A1 (es)	2000-08-05
HUP0102505A3 (en)	2002-12-28
KR20010052852A (ko)	2001-06-25
ZA993975B (en)	2000-12-15
AP9901582A0 (en)	1999-06-30
HRP20000859A2 (en)	2001-04-30
MA26652A1 (fr)	2004-12-20
NO20006312L (no)	2000-12-12
OA11505A (en)	2004-05-07
JP2002518326A (ja)	2002-06-25
AU4054799A (en)	2000-01-05
PA8475901A1 (es)	2000-05-24
TNSN99124A1 (fr)	2005-11-10
PL344981A1 (en)	2001-11-19
IS5691A (is)	2000-10-27
TR200003544T2 (tr)	2001-04-20
HUP0102505A2 (hu)	2001-11-28
IL138630A0 (en)	2001-10-31
EA200001186A1 (ru)	2001-06-25
SK18912000A3 (sk)	2001-10-08
AR018869A1 (es)	2001-12-12
GT199900087A (es)	2000-12-07
BR9911324A (pt)	2001-04-03
NO20006312D0 (no)	2000-12-12
CA2335134A1 (en)	1999-12-23
CO5070587A1 (es)	2001-08-28
WO1999065486A1 (en)	1999-12-23
BG105041A (en)	2001-08-31

Similar Documents

Publication	Publication Date	Title
AP2001002264A0 (en)	2001-09-30	Sustained release formulations for growth hormone secretagogues.
NO993520L (no)	1999-09-16	Doseringsformer og fremgangsmÕte for Õ bedre erektil dysfunksjon
MXPA05006670A (es)	2005-10-19	Administracion de capsaicinoides.
ES2191329T3 (es)	2003-09-01	Utilizacion de xantofilos en medicamentos para la mejora de la duracion de la funcion muscular o el tratamiento de trastornos o enfermedades musculares.
PT1083879E (pt)	2005-01-31	Metodos e dispositivos para proporcionar uma terapia de drogas prolongada
UY26701A1 (es)	2001-12-28	Análogos de tetrahidroisoquinolina útiles como secretagogos de la hormona del crecimiento
PT1143937E (pt)	2004-10-29	O e declinio rapido das concentracoes eficazes de droga no plasma formulacoes de libertacao controlada com um arranque rapid
ES2166111T3 (es)	2002-04-01	Uso de tiagabina para el tratamiento de trastornos del sueño.
AU2003301190A8 (en)	2004-07-14	Administration of capsaicinoids
BR0015188A (pt)	2002-11-05	Composições farmacêuticas
ES2152966T3 (es)	2001-02-16	Formas de dosificado farmaceuticas de desleido rapido y procedimiento para su preparacion.
HUP0101427A2 (hu)	2001-08-28	Pezsgő készítmények
DE69332856D1 (de)	2003-05-15	Haarnadelförmiges ribozym
CY1109661T1 (el)	2014-08-13	5-cnac ως παραγοντας για χορηγηση απο το στομα τμηματων παραθορμονης
DK1471892T3 (da)	2009-12-07	Transdermalt terapeutisk system til parkinsons sygdom, der inducerer höje rotigotinplasmaniveauer
HN1999000097A (es)	1999-11-03	Terapia de combinacion para la fragilidad muscoloesqueletica
GT199900066A (es)	2000-10-31	Combinaciones terapeuticas que comprenden un modulador del receptor de estrogenos selectivo y hormona paratiroidea.
HUP0101528A2 (hu)	2001-11-28	LHRH antagonisták és antiösztrogének alkalmazása termékenységi rendellenességek kezelésére
ES2136954T3 (es)	1999-12-01	Utilizacion de al menos un agua termal de vichy como antagonista de sustancia p.
ES2159357T3 (es)	2001-10-01	Derivados terpenoides (sarcodictinas) utiles como agentes antitumorales.
ES2187156T3 (es)	2003-05-16	Terapia antidepresiva.
AR034037A1 (es)	2004-01-21	Inhibidor de aromatasa en dosis multiples para tratar la infertilidad
MXPA01007952A (es)	2004-03-26	Formulaciones a base de l-arginina para tratar enfermedades, y metodos para usarlas.
ES2168562T3 (es)	2002-06-16	Medicamentos analgesicos a base de combinaciones con tramadol.
UY27920A1 (es)	2004-02-27	Combinaciones de epinastina, pseudoefedrina y metilefedrina como nuevas formulaciones farmaceuticas